Litcius/Paper detail

Drug interactions with Bruton’s tyrosine kinase inhibitors: clinical implications and management

Karen Fancher, Jeremy J. Pappacena

2020Cancer Chemotherapy and Pharmacology18 citationsDOI

Topics & Concepts

IbrutinibBruton's tyrosine kinaseDrugTyrosine kinasePharmacologyFood and drug administrationMedicineReceptorImmunologyInternal medicineChronic lymphocytic leukemiaLeukemiaChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsPI3K/AKT/mTOR signaling in cancer
Drug interactions with Bruton’s tyrosine kinase inhibitors: clinical implications and management | Litcius